Responsiveness of efficacy endpoints in clinical trials with over the counter analgesics for headache.

about

Pain relief that matters to patients: systematic review of empirical studies assessing the minimum clinically important difference in acute pain Detecting meaningful changes in trials of headache treatments: which outcome measure is best?

P2860

Q36284882-2EBB53B2-966E-43A5-AB6B-6FE2AB80D256 Q44833511-36BEA213-277C-4771-85CE-C6ECCD123A9F

P2860

Responsiveness of efficacy endpoints in clinical trials with over the counter analgesics for headache.

Item

http://www.wikidata.org/entity/Q39245487

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Responsiveness of efficacy end ...... unter analgesics for headache.

@en

Responsiveness of efficacy end ...... unter analgesics for headache.

@nl

type

Item

label

Responsiveness of efficacy end ...... unter analgesics for headache.

@en

Responsiveness of efficacy end ...... unter analgesics for headache.

@nl

prefLabel

Responsiveness of efficacy end ...... unter analgesics for headache.

@en

Responsiveness of efficacy end ...... unter analgesics for headache.

@nl

P1476

Responsiveness of efficacy end ...... unter analgesics for headache.

@en

P2093

Barbara Peil

http://www.w3.org/2001/XMLSchema#string

Bernhard Aicher

http://www.w3.org/2001/XMLSchema#string

Hubertus Peil

http://www.w3.org/2001/XMLSchema#string

P2860

The fixed combination of acetylsalicylic acid, paracetamol and caffeine is more effective than single substances and dual combination for the treatment of headache: a multicentre, randomized, double-blind, single-dose, placebo-controlled parallel gr

Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance

Treatment satisfaction, functional status, and health-related quality of life of migraine patients treated with almotriptan or sumatriptan.

Acute migraine treatment outcome measures: a clinician's view.

Drug comparisons: why are they so difficult?

Assessing the efficacy of drugs for the acute treatment of migraine: issues in clinical trial design.

Patient perceptions and treatment preferences in migraine management.

Responsiveness and minimal important differences for patient reported outcomes.

Methodological issues in systematic reviews of headache trials: adapting historical diagnostic classifications and outcome measures to present-day standards.

Meeting patient expectations in migraine treatment: what are the key endpoints?

P304

953-962

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/0333102412452047

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Hans-Christoph Diener

P577

2012-07-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22763497

http://www.w3.org/2001/XMLSchema#string

P921

Aɣaarnhom

Responsiveness of efficacy endpoints in clinical trials with over the counter analgesics for headache.

about

P2860

P2860

Responsiveness of efficacy endpoints in clinical trials with over the counter analgesics for headache.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921